Back
Nuvectis Pharma Vs. Harrow Industry Stock Comparison
Sell
11
NVCT
Nuvectis Pharma
Last Price:
4.68
Seasonality Move:
33.69%
Sell
35
HROW
Harrow
Last Price:
35.47
Seasonality Move:
-3.35%
Sell
11
Nuvectis Pharma (NVCT)
is a Sell
Is Nuvectis Pharma a Buy, Sell or Hold?
- The current Nuvectis Pharma [NVCT] share price is $4.70. The Score for NVCT is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
- NVCT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
35
Harrow (HROW)
is a Sell
Is Harrow a Buy, Sell or Hold?
- The current Harrow [HROW] share price is $35.50. The Score for HROW is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- HROW is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
NVCT Stock Price Chart
What is Nuvectis Pharma's stock price today?
-
The Nuvectis Pharma share price today is $4.70
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVCT is experiencing slight buying pressure.
NVCT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.6 | Sell |
Relative Strength Index (14 RSI): | 37.53 | Sell |
Chaikin Money Flow: | 3113 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.76 - 8.06) | Sell |
Bollinger Bands (100): | (5.29 - 7.85) | Sell |
HROW Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.53 | Sell |
Relative Strength Index (14 RSI): | 32.87 | Sell |
Chaikin Money Flow: | -207530 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (37.15 - 46.67) | Sell |
Bollinger Bands (100): | (34.07 - 50.31) | Sell |
NVCT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.78 | Sell |
20-day SMA: | 4.94 | Sell |
50-day SMA: | 6.55 | Sell |
200-day SMA: | 6.95 | Sell |
8-day EMA: | 4.81 | Sell |
20-day EMA: | 5.33 | Sell |
50-day EMA: | 6.09 | Sell |
200-day EMA: | 7.12 | Sell |
HROW Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.77 | Sell |
20-day SMA: | 39.93 | Sell |
50-day SMA: | 46.28 | Sell |
200-day SMA: | 28.92 | Buy |
8-day EMA: | 37.84 | Sell |
20-day EMA: | 40.36 | Sell |
50-day EMA: | 42.71 | Sell |
200-day EMA: | 32.95 | Buy |
Nuvectis Pharma Earnings Growth & NVCT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Harrow Earnings Growth & HROW Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and an increase next year of $1.30 per share.
Nuvectis Pharma Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Harrow Technical Analysis
Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 6 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |